Prevalence of SARS-CoV-2 variants in Italy (ISS report n. 11)
Prevalence of SARS-CoV-2 variants of concern in Italy (adapted from the eleventh ISS genomic surveillance report)
Published: 22 November 2021
The I-Co-Gen platform developed by the Italian National Institute of Health (ISS), and released in April 2021, is currently the most up to date and reliable system for the analysis and collection of SARS-CoV-2 genomic sequences in Italy. Since its release the Italian National Institute of Health (ISS), supported by the Bruno Kessler Foundation and in collaboration with the Italian Ministry of Health, the Regional administrations and the Autonomous Provinces (PPAA), have started an ongoing and coordinated effort for the accurate mapping of the spread of SARS-CoV-2 variants in Italy based on the data incorporated in I-Co-Gen. Results are released periodically in the form of brief reports (further details here). This highlight provides a brief overview of the main results presented in the most recent report (data updated to September 28th 2021). Data from the previous report (August 24th 2021) are also included to facilitate the comparison.
According to the most recent ISS report (genomic data updated to September 28th 2021), all the isolates of SARS-CoV-2 sampled in our country belong to the Delta variant of the virus (lineage B.1.617.2 and derivative lineages AY.*). Consequently, the prevalence of the Delta variant is equal to 100% in all the Regions/PPAA and no cases of COVID-19 associated with other VOC (either Beta (B.1.351) or Gamma (P.1)) have been reported at this time. Finally, following the September 3rd decision by ECDC to descale Alpha from the status of VOC (see link for more details), this variant is not included in the current report.
To obtain detailed information concerning the data included in the report, the methods applied and the technical limitations of the survey, please refer to the complete report as available on the ISS website at the following links (italian only):